Exciting clinical trials will be presented across four Clinical Trials Plenary Sessions and three Clinical Trials Minisymposia, each highlighting advances in a specific subject area.

Monday’s plenary platform will present four technologies helping to chart new horizons in oncology by advancing our understanding of cancer and developing better therapies for patients.

This three-part series will delve into behind-the-scenes strategies in oncology drug design and development, offering expert insight into the next-generation landscape.

An important panel discussion, Cancer Research at a Crossroads: Sustaining Progress Against Cancer for the Benefit of Patients, will examine the impact of recent federal actions on clinical trials, scientific careers, and patient access to new treatments.

The theme of this year’s scientific program is a reminder of our purpose for these next few days and beyond. Moving science forward and improving patients’ lives through research and education are central to the mission to prevent and cure all cancers.

Don’t miss notable Educational Sessions and Methods Workshops, the career fair, and more, say Program Committee Chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD.

The plenary program of the AACR Annual Meeting 2025 will kick off Saturday afternoon by spotlighting exciting advances in the understanding of cancer evolution.

Programming at the Annual Meeting will feature the latest insights into how researchers are using Project GENIE, a publicly accessible registry of real-world, clinico-genomic data from 20 cancer centers worldwide.

A distinguished slate of cancer researchers and physician-scientists will present award lectures from Sunday through Wednesday.

The AACR will recognize leaders from government and the advocacy community during the AACR Annual Meeting 2025.